Rimegepant
Common brands: Nurtec Odt, Tylenol Extra Strength, Emgality, Tylenol Regular Strength, Vitamin D
Top reporter: Pfizer Laboratories Div Pfizer Inc
Nonsteroidal Anti-inflammatory Drug [EPC]Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Benzodiazepine [EPC]Provitamin D2 Compound [EPC]Acetylcholine Release Inhibitor [EPC]
12,254
Total Reports
6,751
Serious Reports
104
Death Reports
30
Reported Reactions
Death Report Ratio: Low (0.85%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Rimegepant.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DRUG INEFFECTIVE | 4,009 | |
| 2 | NAUSEA | 1,143 | |
| 3 | MIGRAINE | 834 | |
| 4 | HEADACHE | 748 | |
| 5 | THERAPEUTIC PRODUCT EFFECT INCOMPLETE | 643 | |
| 6 | OFF LABEL USE | 492 | |
| 7 | DIZZINESS | 447 | |
| 8 | FATIGUE | 425 | |
| 9 | VOMITING | 366 | |
| 10 | FEELING ABNORMAL | 319 | |
| 11 | PRODUCT DOSE OMISSION ISSUE | 279 | |
| 12 | SOMNOLENCE | 279 | |
| 13 | PAIN | 276 | |
| 14 | RASH | 272 | |
| 15 | PRURITUS | 245 | |
| 16 | ABDOMINAL PAIN UPPER | 240 | |
| 17 | THERAPEUTIC PRODUCT EFFECT DECREASED | 235 | |
| 18 | DYSPNOEA | 219 | |
| 19 | HYPERSENSITIVITY | 216 | |
| 20 | ANXIETY | 211 | |
| 21 | COVID-19 | 211 | |
| 22 | DIARRHOEA | 208 | |
| 23 | CONSTIPATION | 195 | |
| 24 | ILLNESS | 189 | |
| 25 | ABDOMINAL DISCOMFORT | 185 | |
| 26 | MALAISE | 180 | |
| 27 | THERAPEUTIC PRODUCT EFFECT VARIABLE | 178 | |
| 28 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 176 | |
| 29 | INJECTION SITE PAIN | 171 | |
| 30 | EXPOSURE DURING PREGNANCY | 162 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.